We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Long-acting injectable formulations of paliperidone, ...
Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection. The Food and Drug Administration (FDA) has approved Erzofri ® (paliperidone palmitate) ...
Background: To compare the efficacy and tolerability of paliperidone extended-release (ER) with risperidone immediate-release using propensity score methodology. Methods: Six double-blind, randomized, ...
Please provide your email address to receive an email when new articles are posted on . Paliperidone palmitate appeared to benefit Black patients with recent-onset schizophrenia or schizophreniform ...
ABILIFY MAINTENA (aripiprazole) 300mg and 400mg ext-rel injectable suspension Otsuka and Lundbeck announced results from the first-of-its-kind study comparing the effectiveness of aripiprazole ...
PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI ® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in ...
SAN FRANCISCO (MarketWatch) -- Johnson & Johnson's pharmaceutical research and development unit said after the closing bell on Wednesday that its investigational medication, paliperidone extended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback